Clinical Trials on Specific Learning Disorder

Total 144704 results

Kaiser Permanente
National Cancer Institute (NCI)

Completed

Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Centre, Singapore

Completed

Irinotecan in Treating Asian Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Singapore
Mayo Clinic
National Cancer Institute (NCI)

Completed

Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

Unspecified Adult Solid Tumor, Protocol Specific

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Aging Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Pittsburgh
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

Unspecified Adult Solid Tumor, Protocol Specific

United States
Herbert Hurwitz, MD
National Cancer Institute (NCI)

Completed

Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Withdrawn

Icotinib Hydrochloride in Treating Patients With Advanced Cancers

Unspecified Adult Solid Tumor, Protocol Specific
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Yale University
National Cancer Institute (NCI)

Terminated

High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Unspecified Adult Solid Tumor, Protocol Specific

Canada
National Cancer Institute (NCI)

Completed

Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Pittsburgh
National Cancer Institute (NCI)

Withdrawn

Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
Children's Hospital Medical Center, Cincinnati
National Cancer Institute (NCI)

Unknown

Dietary Soy Isoflavones for the Prevention of Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery

Unspecified Adult Solid Tumor, Protocol Specific

United States
Virginia Polytechnic Institute and State University
National Cancer Institute (NCI)

Completed

An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

3-AP in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Registration and Informed Consent Study for the Childhood Cancer Research Network

Unspecified Childhood Solid Tumor, Protocol Specific

United States, Canada
Texas Children's Cancer Center

Completed

Irinotecan in Treating Children With Refractory or Progressive Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific

United States
Cancer Research UK

Completed

Geldanamycin Analogue in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

T138067 Sodium in Treating Patients With Advanced Refractory Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Polyglutamate Camptothecin in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Combination Chemotherapy In Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Sirius Medicine

Completed

Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jewish General Hospital
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants (IRB 2004-535)

Unspecified Adult Solid Tumor, Protocol Specific

United States, United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Etoposide and Celecoxib in Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

BMS-599626 in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

Completed

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

Unspecified Adult Solid Tumor, Protocol Specific

United States
European Organisation for Research and Treatment...

Completed

Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care

Unspecified Adult Solid Tumor, Protocol Specific

France, United Kingdom, Belgium, Spain, Sweden
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Study of Hair Samples From Patients With Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Georgetown University
National Cancer Institute (NCI)

Completed

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

SU5416 and Paclitaxel in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

BMS-214662 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Unspecified Adult Solid Tumor, Protocol Specific
University of Saskatchewan
Heart and Stroke Foundation of Canada

Completed

Examining Physician Counseling to Promote Adoption of Physical Activity: A Controlled Trial

No Specific Conditions Are Being Examined
Ostfold University College

Active, not recruiting

Intervention for Low-performing First Graders in Mathematics

Mathematics Disorder

Norway
The University of Texas Medical Branch, Galveston

Active, not recruiting

Building Long-term Academic Success Through Ongoing Fun Fitness Program (BLASTOFF)

Reading Disorder

United States
MED-EL Elektromedizinische Geräte GesmbH

Completed

The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

Hearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, Mixed

Austria, Germany, United Kingdom
Rockefeller University

Completed

Experiments to Test How and Why the Sense of Smell Differs Between People

Specific Anosmias

United States
Tel-Aviv Sourasky Medical Center

Unknown

The Additive Effect of Cognitive Behavioral Treatment (CBT) to Conventional Weight Loss Intervention Program for Young Adults With Intellectual Disabilities

Obesity | Overweight | Learning Disability

Israel
Oticon Medical

Recruiting

Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear

Ear Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, Unilateral

United Kingdom
University of North Carolina, Chapel Hill
Med-El Corporation

Active, not recruiting

Outcomes in Children With Pre-operative Residual Hearing

High Frequency Sensorineural Hearing Impairment | Hearing Disorders in Children

United States

Clinical Trials on Specific Learning Disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations